
AI in MedTech: We need to strike the right balance between innovation and regulation
Stricter regulation is inevitable, so how should Medtech companies react? By Cognizant’s Rohit Alimchandani
Back to Top
Stricter regulation is inevitable, so how should Medtech companies react? By Cognizant’s Rohit Alimchandani
Diane Bullman reveals the difference mentoring made to this year’s participants and looks ahead to the 2025 programme – which includes a new stream run
Clinicians need a culture of education and understanding to get the best out of AI and protect themselves and their patients from inappropriate information, writes
As a service, pharmacy dislikes change, preferring to apply ‘band-aids’ to traditional systems. But the advantages of digitising are now too great to ignore, writes
Digital Health’s Advisory Panel invited members of the Shuri Network to join the panel last year. For Vicki Kong and Elohor Uwadiogbu it was a
Ahead of Rewired 2024, Beverley Bryant, CDIO at Guy’s and St Thomas’ and King’s College
A fundamental shift in the digital capabilities of community pharmacies is opening the door to
As NHS appointment no-shows continue to cost the NHS millions each year, Induction Healthcare’s Paul
Building AI tools into existing models is futile. It is time to go back to
Poor quality data is partly to blame for the failure to shift care out of